A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma
Authors
Keywords
ACC, Salivary cancer, ATRA, Targeted therapy, Head and neck cancer, Retinoic acid
Journal
ORAL ONCOLOGY
Volume 119, Issue -, Pages 105366
Publisher
Elsevier BV
Online
2021-06-03
DOI
10.1016/j.oraloncology.2021.105366
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells
- (2020) Maria V. Yusenko et al. CANCER LETTERS
- Common variants in signaling transcription-factor-binding sites drive phenotypic variability in red blood cell traits
- (2020) Avik Choudhuri et al. NATURE GENETICS
- Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma
- (2019) Vatche Tchekmedyian et al. JOURNAL OF CLINICAL ONCOLOGY
- ACCURACY: phase (P) 2 trial of AL101, a pan-Notch inhibitor, in patients (pts) with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) with Notch activating mutations (Notchact mut).
- (2019) Renata Ferrarotto et al. JOURNAL OF CLINICAL ONCOLOGY
- IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors
- (2019) Andersson et al. Cells
- MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma
- (2019) Yue Jiang et al. ORAL ONCOLOGY
- N-Terminal Truncated Myb with New Transcriptional Activity Produced Through Use of an Alternative MYB Promoter in Salivary Gland Adenoid Cystic Carcinoma
- (2019) Candace A. Frerich et al. Cancers
- Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma
- (2018) Joseph Mandelbaum et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors
- (2017) Renata Ferrarotto et al. JOURNAL OF CLINICAL ONCOLOGY
- T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
- (2017) Alexander C. Huang et al. NATURE
- A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma
- (2017) Priscila H. Goncalves et al. Oncotarget
- A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
- (2016) A. L. Ho et al. ANNALS OF ONCOLOGY
- An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma
- (2016) Yotam Drier et al. NATURE GENETICS
- Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize
- (2016) Stephen R. Adams et al. Nature Communications
- Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma
- (2016) Arya Amini et al. JAMA Otolaryngology-Head & Neck Surgery
- Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations
- (2015) Y. Mitani et al. CLINICAL CANCER RESEARCH
- Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma
- (2015) K. J. Brayer et al. Cancer Discovery
- Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck
- (2013) David J. Thomson et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Clinicopathological study of distant metastases of salivary adenoid cystic carcinoma
- (2013) M. Gao et al. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinically significant copy number alterations and complex rearrangements ofMYBandNFIBin head and neck adenoid cystic carcinoma
- (2012) Marta Persson et al. GENES CHROMOSOMES & CANCER
- A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC
- (2011) N. G. Chau et al. ANNALS OF ONCOLOGY
- The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma
- (2011) A Fehr et al. JOURNAL OF PATHOLOGY
- Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group
- (2010) F. Lo-Coco et al. BLOOD
- Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710
- (2010) B. L. Powell et al. BLOOD
- Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance
- (2010) Y. Mitani et al. CLINICAL CANCER RESEARCH
- Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review
- (2010) Scott A Laurie et al. LANCET ONCOLOGY
- Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck
- (2009) M. Persson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now